Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale
New York, January 7, 2026, 12:25 (EST) — Regular session Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks. The move matters now because investors have been bidding up riskier biotech names again, and ADPT tends to swing with that tone. The SPDR S&P Biotech ETF and the iShares Nasdaq Biotechnology ETF were each up about 2.5% in midday trade. The broader market was also higher, but not by as